Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Research output: Contribution to journalArticle


Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (


External organisations
  • Skåne University Hospital
  • Gambro AB
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Urology and Nephrology


  • critically ill patients, CRRT, hypophosphataemia, intensive care medicine
Original languageEnglish
Pages (from-to)205-210
Number of pages6
JournalClinical Kidney Journal
Issue number2
Publication statusPublished - 2016 Apr 1
Publication categoryResearch